The disparity of biopsy Gleason score of prostate cancer (PCa) with that of the corresponding radical prostatectomy (RP) remains an unsolved problem. We developed and validated radiomics model based on T2-weighted, fat-suppressed T2W, apparent diffusion coefficient and dynamic contrast enhancement images to predict upgrading from biopsy to RP. The radiomics model achieved the area under the curve values of 0.977 and 0.931 for the training and validation cohorts, and outperformed the clinical model combining clinical stage and time from biopsy to RP. The radiomics model could serve as a non-invasive tool for individualized prediction of upgrading of PCa.
This abstract and the presentation materials are available to members only; a login is required.